Please login or register to print this page.

The British Journal
of Cardiology

This website is intended for healthcare professionals only

2010, Volume 17, Issue 04, pages 153-200

EDITORIAL
Br J Cardiol 2010;17:159-60

Lasers vaporised from NICE guideline recommendations for refractory angina 

As from May 2009 the National Institute for Health and Clinical Excellence (NICE) have removed transmyocardial laser revascularisation (TMLR) from the list of treatments for...

Read More

EDITORIAL
Br J Cardiol 2010;17:161-2

Mortality and catheter ablation of atrial fibrillation

Mortality and catheter ablation of atrial fibrillation

The prevalence of atrial fibrillation (AF) in the UK alone is estimated to be 1% of the population (approximately 610,000) and rises with age from...

Read More

MEETING REPORT
Br J Cardiol 2010;17:168-170

Report from the 20th Scientific Meeting of the European Society of Hypertension, Oslo, Norway

Report from the 20th Scientific Meeting of the European Society of Hypertension, Oslo, Norway

Renal denervation (RDN) revisited

A novel, catheter-based technique is looking promising for the treatment of refractory hypertension. Renal sympathetic hyperactivity is associated with the development of...

Read More

NEWS
Br J Cardiol 2010;17:163-5

New NICE guidance on prevention of cardiovascular disease at the population level 

The National Institute for Health and Clinical Excellence (NICE) has published a new guidance on prevention of cardiovascular disease at the population level....

Read More

NEWS
Br J Cardiol 2010;17:163-5

Testosterone trial stopped due to cardiovascular events 

A trial testing testosterone gel in older men with mobility limitations has been stopped early because of an increased risk of cardiovascular events in the...

Read More

NEWS
Br J Cardiol 2010;17:163-5

Apixaban beneficial in atrial fibrillation 

A study of a new drug for atrial fibrillation, apixaban (Pfizer/Bristol-Myers Squibb), has been stopped early because of...

Read More

NEWS
Br J Cardiol 2010;17:163-5

Eplerenone beneficial in mild heart failure 

Another trial stopped early because of benefit is EMPHASIS-HF (Eplerenone in Mild Patients Hospitalisation And SurvIval Study in Heart Failure) which looked at the aldosterone...

Read More

NEWS
Br J Cardiol 2010;17:163-5

Treat individual risk factors not ‘metabolic syndrome’ 

A new study suggests that patients with metabolic syndrome are no more at risk of future myocardial infarction (MI) than those with diabetes or hypertension...

Read More

NEWS
Br J Cardiol 2010;17:163-5

The British Valve Group – a new special interest group

The influence and importance of valve disease is increasing and yet the subject remains under-represented. There is, for example, no group affiliated to the British...

Read More

NEWS
Br J Cardiol 2010;17:163-5

Lp(a) screening recommended by European Atherosclerosis Society 

Patients at moderate to high risk of cardiovascular disease should be screened for elevated Lp(a) and take niacin to lower levels to under 50 mg/dL...

Read More

NEWS
Br J Cardiol 2010;17:163-5

England sees MI reduction after smoking ban 

A new study has confirmed that there has been a significant drop in hospital admissions for myocardial infarction (MI) after the introduction of smoke-free legislation...

Read More

IN BRIEF
Br J Cardiol 2010;17:167

In Brief

In Brief

News in brief from the world of cardiology....

Read More

NEWS
Br J Cardiol 2010;17:163-5

Is the EWTD failing the welfare of junior doctors?

To find out how the European Working Time Directive set up to help improve the welfare of junior doctors seems to be failing in one...

Read More

OBLIQUE VIEW
Br J Cardiol 2010;17:171-2

A glossary of terms used in interventional cardiology: part 2

We continue our series in which Consultant Interventionist Dr Michael Norell takes a sideways look at life in the cath lab…and beyond. In this column,...

Read More

CLINICAL ARTICLE
Br J Cardiol 2010;17:175-9

Meeting the psychological needs of cardiac patients: an integrated stepped-care approach within a cardiac rehabilitation setting

Meeting the psychological needs of cardiac patients: an integrated stepped-care approach within a cardiac rehabilitation setting

Depression and anxiety are commonly experienced by cardiac patients and are associated with reduced quality of life and mortality, but the evidence for the effectiveness...

Read More

CLINICAL ARTICLE
Br J Cardiol 2010;17:181-3

Rehabilitation on the move: teaching cardiac rehabilitation in a novel way

Coronary heart disease is a leading cause of mortality and morbidity worldwide. Risk factor modification through a robust cardiac rehabilitation programme is rewarding and accounts...

Read More

CLINICAL ARTICLE
Br J Cardiol 2010;17:185-9

‘Time is muscle’: aspirin taken during acute coronary thrombosis

‘Time is muscle’: aspirin taken during acute coronary thrombosis

Low-dose aspirin is of value in the long-term management of vascular disease, and the giving of aspirin to patients believed to be experiencing an acute...

Read More

CLINICAL ARTICLE
Br J Cardiol 2010;17:190-3

From patient to plaque. Contemporary coronary imaging – part 2: optical coherence tomography 

From patient to plaque. Contemporary coronary imaging – part 2: optical coherence tomography 

Intra-coronary imaging has become a cornerstone of visualising atherosclerotic coronary artery disease and also to guide the therapy in selected high-risk cases. Optical coherence tomography...

Read More

BOOK REVIEW

Book review – Evidence-based cardiology, 3rd edition

By the very nature of book publishing, a relevant evidence-based textbook is always a hard task to achieve. The editors of Evidence-based cardiology preface this...

Read More

CLINICAL ARTICLE
Br J Cardiol 2010;17:195-200

The role of nucleic acid amplification techniques (NAATs) in the diagnosis of infective endocarditis

The role of nucleic acid amplification techniques (NAATs) in the diagnosis of infective endocarditis

Infective endocarditis (IE) causes high rates of morbidity and mortality. Clinical management is problematic if there are uncertainties over the identity, viability or antibiotic susceptibility...

Read More

Close

You are not logged in

You need to be a member to print this page.
Sign up for free membership, or log in.

Find out more about our membership benefits

Close

You are not logged in

You need to be a member to download PDF's.
Sign up for free membership, or log in.

Find out more about our membership benefits